Adenovector engineered interleukin-2 expressing autologous plasma cell vaccination after high-dose chemotherapy for multiple myeloma - A phase 1 study

S. Trudel, Z. Li, C. Dodgson, S. Nanji, Y. Wan, M. Voralia, M. Hitt, J. Gauldie, F. L. Graham, A. K. Stewart

Research output: Contribution to journal › Article › peer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'Adenovector engineered interleukin-2 expressing autologous plasma cell vaccination after high-dose chemotherapy for multiple myeloma - A phase 1 study'. Together they form a unique fingerprint.

Medicine & Life Sciences